Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$869.9K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
3 of 10 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 28 business days late.
The 56 most recent Form 4 transactions.
| $31.2K |
| Filing ↗ |
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Jun 18 | GYRE | Gyre Therapeutics, INC. | MEXER | 3,000 | $0.75 | $2.3K | +0.4% | Open the original filing on SEC.gov |
| Jun 11 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 2,800 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | GYRE | Gyre Therapeutics, INC. | SSELL | 2,800 | $6.17 | $17.3K | -0.4% | Open the original filing on SEC.gov |
| Jun 11 | GYRE | Gyre Therapeutics, INC. | MEXER | 2,800 | $0.75 | $2.1K | +0.4% | Open the original filing on SEC.gov |
| Jun 10 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 6,418 | — | — | — | Open the original filing on SEC.gov |
| Jun 10 | GYRE | Gyre Therapeutics, INC. | SSELL | 6,418 | $6.21 | $39.9K | -0.9% | Open the original filing on SEC.gov |
| Jun 10 | GYRE | Gyre Therapeutics, INC. | MEXER | 6,418 | $0.75 | $4.8K | +0.9% | Open the original filing on SEC.gov |
| Jun 10 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 10 | GYRE | Gyre Therapeutics, INC. | SSELL | 5,000 | $6.24 | $31.2K | -0.7% | Open the original filing on SEC.gov |
| Jun 10 | GYRE | Gyre Therapeutics, INC. | MEXER | 5,000 | $0.75 | $3.8K | +0.7% | Open the original filing on SEC.gov |
| Jun 9 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 14,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | GYRE | Gyre Therapeutics, INC. | SSELL | 14,500 | $6.14 | $89K | -2.0% | Open the original filing on SEC.gov |
| Jun 9 | GYRE | Gyre Therapeutics, INC. | MEXER | 14,500 | $0.75 | $10.9K | +2.1% | Open the original filing on SEC.gov |
| Jun 9 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | GYRE | Gyre Therapeutics, INC. | SSELL | 3,000 | $6.15 | $18.5K | -0.4% | Open the original filing on SEC.gov |
| Jun 9 | GYRE | Gyre Therapeutics, INC. | MEXER | 3,000 | $0.75 | $2.3K | +0.4% | Open the original filing on SEC.gov |
| Jun 5 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 15,401 | — | — | — | Open the original filing on SEC.gov |
| Jun 5 | GYRE | Gyre Therapeutics, INC. | SSELL | 15,401 | $6.40 | $98.6K | -2.1% | Open the original filing on SEC.gov |
| Jun 5 | GYRE | Gyre Therapeutics, INC. | MEXER | 15,401 | $0.75 | $11.6K | +2.2% | Open the original filing on SEC.gov |
| Jun 4 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 19,575 | — | — | — | Open the original filing on SEC.gov |
| Jun 4 | GYRE | Gyre Therapeutics, INC. | SSELL | 19,575 | $6.13 | $120K | -2.7% | Open the original filing on SEC.gov |
| Jun 4 | GYRE | Gyre Therapeutics, INC. | MEXER | 19,575 | $0.75 | $14.7K | +2.8% | Open the original filing on SEC.gov |
| May 26 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 4,000 | — | — | — | Open the original filing on SEC.gov |
| May 26 | GYRE | Gyre Therapeutics, INC. | SSELL | 4,000 | $6.10 | $24.4K | -0.6% | Open the original filing on SEC.gov |
| May 26 | GYRE | Gyre Therapeutics, INC. | MEXER | 4,000 | $0.75 | $3K | +0.6% | Open the original filing on SEC.gov |
| May 22 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 3,500 | — | — | — | Open the original filing on SEC.gov |
| May 22 | GYRE | Gyre Therapeutics, INC. | SSELL | 3,500 | $6.08 | $21.3K | -0.5% | Open the original filing on SEC.gov |
| May 22 | GYRE | Gyre Therapeutics, INC. | MEXER | 3,500 | $0.75 | $2.6K | +0.5% | Open the original filing on SEC.gov |
| May 21 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 12,820 | — | — | — | Open the original filing on SEC.gov |
| May 21 | GYRE | Gyre Therapeutics, INC. | SSELL | 12,820 | $6.15 | $78.8K | -1.8% | Open the original filing on SEC.gov |
| May 21 | GYRE | Gyre Therapeutics, INC. | MEXER | 12,820 | $0.75 | $9.6K | +1.8% | Open the original filing on SEC.gov |
| May 20 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 9,400 | — | — | — | Open the original filing on SEC.gov |
| May 20 | GYRE | Gyre Therapeutics, INC. | SSELL | 9,400 | $6.15 | $57.8K | -1.3% | Open the original filing on SEC.gov |
| May 20 | GYRE | Gyre Therapeutics, INC. | MEXER | 9,400 | $0.75 | $7.1K | +1.3% | Open the original filing on SEC.gov |
| May 19 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 9,120 | — | — | — | Open the original filing on SEC.gov |
| May 19 | GYRE | Gyre Therapeutics, INC. | SSELL | 9,120 | $6.37 | $58.1K | -1.3% | Open the original filing on SEC.gov |
| May 19 | GYRE | Gyre Therapeutics, INC. | MEXER | 9,120 | $0.75 | $6.8K | +1.3% | Open the original filing on SEC.gov |
| May 18 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 200 | — | — | — | Open the original filing on SEC.gov |
| May 18 | GYRE | Gyre Therapeutics, INC. | SSELL | 200 | $6.62 | $1.3K | <0.1% | Open the original filing on SEC.gov |
| May 18 | GYRE | Gyre Therapeutics, INC. | MEXER | 200 | $0.75 | $150 | +<0.1% | Open the original filing on SEC.gov |
| May 15 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 13,100 | — | — | — | Open the original filing on SEC.gov |
| May 15 | GYRE | Gyre Therapeutics, INC. | SSELL | 13,100 | $6.65 | $87.1K | -1.8% | Open the original filing on SEC.gov |
| May 15 | GYRE | Gyre Therapeutics, INC. | MEXER | 13,100 | $0.75 | $9.8K | +1.9% | Open the original filing on SEC.gov |
| May 14 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 15,580 | — | — | — | Open the original filing on SEC.gov |
| May 14 | GYRE | Gyre Therapeutics, INC. | SSELL | 15,580 | $6.91 | $107.7K | -2.2% | Open the original filing on SEC.gov |
| May 14 | GYRE | Gyre Therapeutics, INC. | MEXER | 15,580 | $0.75 | $11.7K | +2.2% | Open the original filing on SEC.gov |
| Apr 1, 2025 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 50,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 1, 2025 | GYRE | Gyre Therapeutics, INC. | MEXER | 50,000 | $0.75 | $37.5K | +7.7% | Open the original filing on SEC.gov |
| Mar 27, 2025 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 150,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 27, 2025 | GYRE | Gyre Therapeutics, INC. | MEXER | 150,000 | $0.75 | $112.5K | +30.0% | Open the original filing on SEC.gov |
| Mar 26, 2025 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 200,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 26, 2025 | GYRE | Gyre Therapeutics, INC. | MEXER | 200,000 | $0.75 | $150K | +66.7% | Open the original filing on SEC.gov |
| Mar 24, 2025 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 300,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 24, 2025 | GYRE | Gyre Therapeutics, INC. | MEXER | 300,000 | $0.75 | $225K | — | Open the original filing on SEC.gov |